Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_assertion type Assertion NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_head.
- NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_assertion description "[Further, oral administration of silymarin (500?mg/kg body weight/2� a week) significantly inhibited (60%, P?<?0.01) the growth of BRAF-mutated A375 melanoma tumor xenografts, and this was associated with: (i) inhibition of cell proliferation; (ii) induction of apoptosis of tumor cells; (iii) alterations in cell cycle regulatory proteins; and (iv) reduced expression of tumor angiogenic biomarkers in tumor xenograft tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_provenance.
- NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_assertion evidence source_evidence_literature NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_provenance.
- NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_assertion SIO_000772 25174976 NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_provenance.
- NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_assertion wasDerivedFrom befree-2016 NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_provenance.
- NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_assertion wasGeneratedBy ECO_0000203 NP1215573.RAYeTWnlfzKRFiEytz5OaYhlKU7kXNB-DQ9x3CPI72lLM130_provenance.